重症监护病房脓毒性休克合并急性肾损伤患者肾功能恢复的影响因素分析
该回顾性研究纳入2017年1月至2019年6月武汉大学中南医院重症医学科收治的323例脓毒性休克合并AKI患者,按肾功能变化分为肾功能改善组(195例)和肾功能未改善组(128例)。单因素分析筛选出组间差异有统计学意义的指标后进行岭回归分析,发现APACHE II、SOFA、SCr、BUN、心率、白细胞计数、液体平衡及去甲肾上腺素最大输注速度是肾功能未改善的影响因素(均P<0.05)。ROC分析显示APACHE II、SOFA、BUN、NEmax四者联合的预测价值最高(AUC 0.863,95%CI 0.821-0.899),高于任一单独指标及APACHE II+SOFA+SCr+NEmax组合(均P<0.01)。
要点
- 脓毒性休克合并AKI患者中,APACHE II、SOFA、SCr、BUN、心率、WBC、液体平衡及NEmax是肾功能未改善的影响因素(岭回归t值5.507、3.690、2.026、4.815、2.512、2.114、3.532、3.735,均P<0.05)。
- APACHE II、SOFA、BUN、NEmax四者联合预测肾功能未改善的AUC为0.863(95%CI 0.821-0.899),高于APACHE II、SOFA、BUN、SCr、NEmax任一单独指标(AUC分别为0.755、0.722、0.738、0.743、0.748,均P<0.01)。
- 四者联合的AUC也高于APACHE II+SOFA+SCr+NEmax组合(0.863 vs. 0.825,P<0.01)。
- 该研究为单中心回顾性分析,纳入323例患者,肾功能改善组195例、未改善组128例。
适用人群与场景
- 2017年1月至2019年6月武汉大学中南医院重症医学科收治的脓毒性休克合并急性肾损伤患者,共323例符合纳入标准。
- 按肾功能变化分为肾功能改善组(195例)和肾功能未改善组(128例)。
研究设计与关键结果
- 研究类型为单中心回顾性分析,纳入323例脓毒性休克合并AKI患者,肾功能改善组195例、未改善组128例。
- 单因素分析显示两组间APACHE II、SOFA、GCS、心率、SCr、BUN、K+、WBC、CVPmax、ΔCVP、液体平衡、LACmax及NEmax差异有统计学意义。
- 岭回归分析显示APACHE II、SOFA、SCr、BUN、心率、WBC、液体平衡及NEmax是肾功能未改善的影响因素(t值分别为5.507、3.690、2.026、4.815、2.512、2.114、3.532、3.735,均P<0.05)。
- ROC分析显示APACHE II、SOFA、BUN、NEmax四者联合的AUC最高,为0.863(95%CI 0.821-0.899),高于APACHE II、SOFA、BUN、SCr、NEmax任一单独指标(AUC分别为0.755、0.722、0.738、0.743、0.748,均P<0.01)。
- 四者联合的AUC也高于APACHE II+SOFA+SCr+NEmax组合(0.863 vs. 0.825,P<0.01)。
证据类型、等级与局限
- 证据类型:单中心回顾性分析。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为APACHE II、SOFA、SCr、BUN、心率、WBC、液体平衡及NEmax是脓毒性休克合并AKI患者肾功能未改善的影响因素。
- 作者认为APACHE II、SOFA、BUN、NEmax四者联合对肾功能恢复具有较高的预测价值。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
OBJECTIVE: To analyze multiple factors that may affect renal function in septic shock patients with acute kidney injury (AKI) in the intensive care unit (ICU), in order to find factors of predictive value for renal function change in those patients.
METHODS: Septic patients with AKI admitted to department of critical care medicine of Wuhan University Zhongnan Hospital from January 2017 to June 2019 were enrolled, and the patients were divided into renal function improvement group and renal function non-improvement group according to their renal function change. Baseline, laboratory and clinical indicators of them were collected to conduct retrospective analysis. Comparing the difference of each index between the two groups, the statistically significant indexes in the univariate analysis were selected to perform ridge regression analysis. The receiver operating characteristic (ROC) curve and its 95% confidence interval (95%CI) were used to analyze the predictive value of each influencing factor on the recovery of renal function in patients.
RESULTS: A total of 323 patients met the inclusion criteria, and 195 of them were divided into renal function improvement group while the other 128 of them into the renal function non-improvement group. Univariate analysis showed that, there was significantly difference in acute physiology and chronic health evaluation II (APACHE II), sequential organ failure assessment (SOFA), Glasgow coma score (GCS), heart rate (HR), serum creatinine (SCr), blood urea nitrogen (BUN), potassium (K+), white blood cell count (WBC), maximum central venous pressure (CVPmax), maximum-minimum central venous pressure distance (ΔCVP), fluid balance, maximum lactic acid (LACmax), and maximum norepinephrine infusion speed (NEmax) between the renal function improvement group and the renal function non-improvement group. Ridge regression analysis of those indexes found that APACHE II, SOFA, SCr, BUN, HR, WBC, fluid balance, and NEmax were influential factors of non-improvement renal function (t values were 5.507, 3.690, 2.026, 4.815, 2.512, 2.114, 3.532, 3.735, all P < 0.05). ROC analysis found the predictive value combining the APACHE II, SOFA, BUN, NEmax was the highest [the area under ROC curve (AUC) and 95%CI: 0.863 (0.821-0.899)], which had a higher AUC than any of APACHE II, SOFA, BUN, SCr and NEmax [AUC and 95%CI: 0.863 (0.821-0.899) vs. 0.755 (0.705-0.801), 0.722 (0.670-0.770), 0.738 (0.686-0.785), 0.743 (0.692-0.790), 0.748 (0.697-0.794), all P < 0.01], and so did it when compared to APACHE II, SOFA, SCr and NEmax combination [AUC and 95%CI: 0.863 (0.821-0.899) vs. 0.825 (0.799-0.865), P < 0.01].
CONCLUSIONS: APACHE II, SOFA, SCr, BUN, HR, WBC, fluid balance, and NEmax are the positive influencing factors for patients without renal function improvement. The combination of APACHE II, SOFA, BUN, and NEmax had a relatively high predictive value for renal function recovery.
参考来源
- He L, Su L, Zhang J, et al. [Analysis of factors influencing recovery of renal functions in septic shock patients in intensive care unit with acute kidney injury]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020. PMID: 32275006. doi:10.3760/cma.j.cn121430-20200106-00037
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。